"Combined deep learning and molecular docking simulations approach ..."

Muhammad U. Anwaar et al. (2022)

> Home

Details and statistics

DOI: 10.1016/J.COMPBIOMED.2021.105049

access: closed

type: Journal Article

metadata version: 2022-08-16

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/cbm/AnwaarAAKRORKSJ22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/cbm/AnwaarAAKRORKSJ22
Muhammad U. Anwaar, Farjad Adnan, Asma Abro, Rayyan A. Khan, Asad U. Rehman, Muhammad Osama, Christopher Rainville, Suresh Kumar, David E. Sterner, Saad Javed, Syed B. Jamal, Ahmadullah Baig, Muhammad R. Shabbir, Waseh Ahsan, Tauseef R. Butt, Muhammad Z. Assir:
Combined deep learning and molecular docking simulations approach identifies potentially effective FDA approved drugs for repurposing against SARS-CoV-2. Comput. Biol. Medicine 141: 105049 (2022)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.